Monthly Archives: June 2010

اپشر-اسمتھ لیبارٹریز نے ITI-111 (نیسل میڈازولم) کو سی این ایس ڈیولپمنٹ پائپ لائن میں شامل کر لیا

میپل گروو، منیسوٹا، 28 جون/پی آرنیوزوائر-ایشیانیٹ/ چھ ماہ میں اگلے معاہدے نے سی این ایس کے پورٹ فولیو کو چار پروگرامز تک توسیع دے دی اپشر-اسمتھ لیبارٹریز انکارپوریٹڈ نے آج [...]

Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline

MAPLE GROVE, Minn., June 28 /PRNewswire-AsiaNet/ – Second Deal in Six Months Expands CNS Portfolio to Four Programs Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to [...]

Type 2 Diabetes Patients with Long-Standing Disease Achieved Glycaemic Control When BYETTA(R) (exenatide) Injection Was Added to Insulin Glargine

ORLANDO, Fla., June 26 /PRNewswire-AsiaNet/ – Study Presented at ADA 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from the first double-blind, [...]

Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) (exenatide) Injection Therapy: Data Presented at ADA 2010

ORLANDO, Fla., June 26 /PRNewswire-AsiaNet/ – Study Showed Improvements Compared to Insulin Glargine Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from a [...]